• Korean journal of dermatology
• /
• v.56 no.10
• /
• pp.647-649
• /
• 2018

• The Journal of the Korean dental association
• /
• v.10 no.1
• /
• pp.29-33
• /
• 1972

The author has studied histochemically on the giant cells appeqring in the 10 giant cell lesions which had been collected from the biopsies at the deaprtment of oral pathology, college of dentistry, Seoul national university and dental sections of several hospitals in Seoul. The results obtained were as follows: 1. The giant cells varied in size had 2 to 10 nuclei without any mitotic figures. 2. The giant cells showed high granularity in cytoplasm, extreme irregularity in outline of nuclear and cytoplasmic membrane, and very large and prominent nucleoli. 3. The giant cells were reacted moderately by Periodic Acid-Schiffraction. 4. The chtoplams of giant cells were stained moderately of deeply with Pyronin, and their nuclei with Methyl green. 5. In the sections stained with Iron-Hematoxylin, the giant cells showed microvacules and fine granular type mitochondria aggregated close to nuclei but not phagocytosed materials.

• The Journal of the Korean bone and joint tumor society
• /
• v.5 no.1
• /
• pp.23-28
• /
• 1999

Between Sep. 1986 and Mar. 1996, twenty four patients with recurrent giant cell tumor of their long bones were treated and followed up for more than two years. We applied three different modalities for treatment: curettage with bone graft, curettage and packing with polymethylmethacrylate, wide excision with or without reconstruction. During the average 51.5 months after operation(24-97 months), two of three patients who underwent curettage with bone graft showed recurrence. Patients who underwent wide excision showed no recurrence. Five of fifteen patients who underwent curettage and packing with polymethylmethacrylate showed recurrence. Four of seven who showed recurrence were treated with reapplication of curettage and packing with polymethylmethacrylate. All four patients showed no recurrence, and two of them have been followed up for more than two years. We suggest that the curettage and packing with polymethylmethacrylate is an effective treatment modality of the recurrent giant cell tumor.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• v.23 no.2
• /
• pp.180-187
• /
• 2020

Giant cell hepatitis with autoimmune hemolytic anemia (AHA) is a rare disease of infancy characterized by the presence of both Coombs-positive hemolytic anemia and progressive liver disease with giant cell transformation of hepatocytes. Here, we report a case involving a seven-month-old male infant who presented with AHA followed by cholestatic hepatitis. The clinical features included jaundice, pallor, and red urine. Physical examination showed generalized icterus and splenomegaly. The laboratory findings suggested warm-type AHA with cholestatic hepatitis. Liver biopsy revealed giant cell transformation of hepatocytes and moderate lobular inflammation. The patient was successfully treated with four doses of rituximab. Early relapse of hemolytic anemia and hepatitis was observed, which prompted the use of an additional salvage dose of rituximab. He is currently in clinical remission.

• Journal of Korean Foot and Ankle Society
• /
• v.6 no.1
• /
• pp.117-120
• /
• 2002

We experienced 1 case of the giant cell tumor of the tendon sheath penetrating the middle phalanx of the third toe. Patient had painless huge mass all around the third phalanx of the foot which made a penetrating hole through the middle phalanx of the third toe in plain radiography. The period from the onset of the symptom until operation was about several years. The mass extended to the base of the distal phalanx and compressed digital nerves and vessels. Patient presented with a chief complaint of the pain on the plantar aspect of the toe and limitation of the motion of the distal interphalangeal joint. Giant cell tumor of the tendon sheath was cured by total en block resection.

• The Journal of the Korean bone and joint tumor society
• /
• v.7 no.2
• /
• pp.73-79
• /
• 2001

Giant cell tumor is usually found around the knee joint, especially in the distal femur or proximal tibia. Despite being classified as benign, it has unusual biological behavior of local aggressiveness and tend to have severely destructive lesion and develop rare pulmonary metastasis. Therefore, when the patient is presented to the physician with an expansile lytic lesion of challenging clinicopathologic entity extending to subchondral bone, the physician faces up to difficulties in treatment. We report a case of 25 years old patient having recurrent giant cell tumor in the right distal femur which developed metastasis to lung. The primary bone lesion was treated with local curettage and fillings with methylmethacrylate, but when he returned to the hospital two years later, the recurrence had developed with lung metastasis.

• Journal of the Korean Arthroscopy Society
• /
• v.15 no.2
• /
• pp.113-116
• /
• 2011

Reports of localized giant cell tumor arising from the posterior cruciate ligament are rare, and its recurrence rate after incomplete excision. We experienced a case of localized giant cell tumor arising from the posterior cruciate ligament that were excised arthroscopically with transseptal approach and pathologically confirmed. The patient showed good clinical result for one year after operation. So we report a case with a review of the literatures.

• The Journal of the Korean bone and joint tumor society
• /
• v.4 no.2
• /
• pp.103-106
• /
• 1998

Giant cell tumor was described by Sir Astley Cooper in 1818. This tumor is considered to be a benign tumor but has problems of recurrence and metastatic change after treatment. Methods of operative treatment of this tumor have included currettage, currettage and bone graft, excision, resection, excision and graft and amputation. We experienced a case of giant cell tumor which involved the distal part of right radius and treated by wide excision and fibular graft. The postoperative courses have been satisfactory because of no recurrence or malignant change. After 6 years and 1 month follow up, the patient was able to return to daily life without any problem.

• The Journal of the Korean bone and joint tumor society
• /
• v.2 no.1
• /
• pp.60-64
• /
• 1996

Giant cell tumor of tendon sheath is a slow-growing, unilateral and solitary lesion that is most commonly seen in the digits of the hand and knee, but occasionally occurs in the hips, ankles, toes and wrists. The lesion is asymptomatic or mildly painful, especially if it is diffuse and located in a major joint. The concepts concerning about the pathogenesis of these lesion have undergone constant revision, which include neoplastic process, inflammation and lipid metabolism. Authors analysized 20 patients with giant cell tumor of tendon sheath about the etiology, clinical findings, pathologic findings and treatment results. The results were as follows: 1. 13 cases were females (65%) and 7 cases were males (35%), and the range of age was from 9 years old to 60 years old. 2. The hand was most frequently involved site in which 14 cases (70%) were included, and the foot was involved in 5 cases (25%). 3. Solitary lesions were 15 cases and multiple lesions were 5 cases. 4. Radiographically, in 3 cases bony erosion was seen. 5. All cases were treated by surgical excision and presented no recurrence. In conclusion, the giant cell tumor of tendon sheath, which has been considered to be benign tumorous conditions appeared to be necessary for complete surgical excision to prevent recurrence.

• The Journal of the Korean bone and joint tumor society
• /
• v.12 no.1
• /
• pp.15-22
• /
• 2006

Purpose: This study was designed to investigate the clinical and oncological results of giant cell tumor, treated with electrocautery as an adjuvant. Materials and Methods: We evaluated 47 giant cell tumors treated in both institution from 1989 to 2004, retrospectively. We treated all 47 cases with intralesional curettage and speed burring and followed electrocautery as an local adjuvant. Results: The mean follow up periods was 44 months and ranged from 12 to 180 months. The local recurrence occurred in 8 patients (17%) and one case lung metastasis was found. There was one case complication (septic knee) associated with electrocautery as an adjuvant. Conclusions: We thought electrocautery was feasible adjuvant treatment method of giant cell tumor, because it is very convenient technique, and the local recurrence rate was similar to any other methods.